Aaron Schuchart

Aaron Schuchart is the President and CEO of Aether Therapeutics. Aaron is a multi-faceted leader with more than 30 years of operational, financial management, and business development experience. He has spent much of his career structuring and negotiating biopharma transactions, raising capital, and forming new ventures. Prior to Aether, he was Chief Business Officer at two publicly traded biotech companies focused on rare diseases and cancer. Previously he was part of the early management team for Coherus Biosciences, which developed a protein engineering platform from start-up into a late stage publicly traded company. He held senior business development roles at Amgen and Novartis and was Managing Director of ProAltus Partners, a boutique advisory firm providing commercial strategy and deal support to early stage companies. He has a BBA in Accounting from Texas Tech University and an MBA in Finance from the Anderson School at UCLA.